Patient gender does not affect outcome after transcatheter aortic valve implantation (TAVI)
Standard
Patient gender does not affect outcome after transcatheter aortic valve implantation (TAVI). / Diemert, Patrick; Seiffert, Moritz; Schnabel, Renate; Wilde, Sandra; Conradi, Lennart; Schirmer, Johannes; Koschyk, Dietmar; Reichenspurner, Herrmann; Baldus, Stephan; Treede, Hendrik; Blankenberg, Stefan.
in: J HEART VALVE DIS, Jahrgang 22, Nr. 6, 11.2013, S. 789-793.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Patient gender does not affect outcome after transcatheter aortic valve implantation (TAVI)
AU - Diemert, Patrick
AU - Seiffert, Moritz
AU - Schnabel, Renate
AU - Wilde, Sandra
AU - Conradi, Lennart
AU - Schirmer, Johannes
AU - Koschyk, Dietmar
AU - Reichenspurner, Herrmann
AU - Baldus, Stephan
AU - Treede, Hendrik
AU - Blankenberg, Stefan
PY - 2013/11
Y1 - 2013/11
N2 - BACKGROUND AND AIM OF THE STUDY: Female gender has recently been suggested to predict a beneficial outcome and lower mortality following transcatheter aortic valve implantation (TAVI). The study aim was to address gender differences in outcome following TAVI and potentially to replicate these findings.METHODS: The present single-center prospective registry of 326 patients with severe aortic stenosis treated by TAVI between 2008 and 2011 consisted of 181 women and 145 men.RESULTS: The procedural risk was not significantly different between men and women at baseline. For all-cause mortality no difference was observed at 30 days and at 12 months after TAVI.CONCLUSION: While several baseline characteristics between men and women treated by TAVI were shown to be different among the study population, no difference was observed in survival between both genders.
AB - BACKGROUND AND AIM OF THE STUDY: Female gender has recently been suggested to predict a beneficial outcome and lower mortality following transcatheter aortic valve implantation (TAVI). The study aim was to address gender differences in outcome following TAVI and potentially to replicate these findings.METHODS: The present single-center prospective registry of 326 patients with severe aortic stenosis treated by TAVI between 2008 and 2011 consisted of 181 women and 145 men.RESULTS: The procedural risk was not significantly different between men and women at baseline. For all-cause mortality no difference was observed at 30 days and at 12 months after TAVI.CONCLUSION: While several baseline characteristics between men and women treated by TAVI were shown to be different among the study population, no difference was observed in survival between both genders.
KW - Aged
KW - Aged, 80 and over
KW - Aortic Valve Stenosis/diagnosis
KW - Cardiac Catheterization/adverse effects
KW - Chi-Square Distribution
KW - Female
KW - Germany
KW - Heart Valve Prosthesis Implantation/adverse effects
KW - Humans
KW - Kaplan-Meier Estimate
KW - Male
KW - Prospective Studies
KW - Registries
KW - Risk Factors
KW - Severity of Illness Index
KW - Sex Factors
KW - Treatment Outcome
M3 - SCORING: Journal article
C2 - 24597399
VL - 22
SP - 789
EP - 793
IS - 6
ER -